Addiction News and Research

RSS

Research shows free vapes in emergency rooms aid smoking cessation

Experimenting with commercially available vapes may be important for some people's success in giving up smoking, according to new research.

11 Sep 2024

New study explores the potential of hormone therapy for opioid recovery

In the midst of America's growing opioid crisis, a much healthier alternative to long-term pain management is emerging - one affectionately known as "the cuddle hormone," or oxytocin.

11 Sep 2024

Flavored e-cigarettes cut smoking rates and toxic exposure in high-risk groups

Access to participant-preferred flavored e-cigarettes significantly reduces smoking rates and exposure to carcinogens among high-risk populations in a recent study.

10 Sep 2024

GLP-1 receptor agonists show promise in treating substance use disorders

A systematic review reveals that GLP-1 receptor agonists may help reduce certain substance use disorders, but findings are inconsistent due to study variability and patient differences.

9 Sep 2024

Best ways to quit smoking: E-cigs, medications, and counseling proven effective in new Cochrane analysis

Recent Cochrane reviews highlight effective smoking cessation interventions, revealing gaps in research and the need for improved tobacco addiction strategies.

9 Sep 2024

Unraveling psychiatric disorders with cutting-edge epigenetic tools

The "Innovators & Ideas: Rising Star" section of Genomic Psychiatry features an illuminating "Genomic Press Interview" with Dr. Pierre-Eric Lutz, a rising star in the field of neuro-epigenetics.

5 Sep 2024

New review highlights top strategies for smoking cessation

A major new scientific review of evidence published in the journal Addiction has identified three top strategies for quitting smoking.

5 Sep 2024

APDI provides $200,000 in grants to advance pediatric substance use disorder devices

The Alliance for Pediatric Device Innovation (APDI), a nonprofit consortium led by Children's National Hospital and funded through the Food and Drug Administration (FDA), announces today the recipients of grants totaling $200,000 to advance pediatric medical devices that improve the monitoring, diagnosis or treatment of youth suffering from substance use disorder and addiction.

4 Sep 2024

Rising popularity of nicotine pouches among youth raises concerns

About half of adults can identify cigarettes and e-cigarettes, but just one in four would recognize oral nicotine pouches, and these easily available products are growing increasingly popular among teens and young adults, according to a recent study commissioned by The Ohio State University Comprehensive Cancer Center – Arthur G. James Hospital and Richard J. Solove Research Institute (OSUCCC – James).

4 Sep 2024

New approach to treat post-COVID symptoms

In a world still grappling with the aftermath of the COVID-19 pandemic, a team of international researchers has proposed a novel approach to treating the persistent symptoms that plague many survivors of viral infections. The study, published on 30 August 2024 in Brain Medicine (ISSN: 2997-2639, Genomic Press, New York), outlines a multimodal treatment strategy that could offer hope to millions suffering from post-acute infectious syndromes (PAIS), including the condition commonly known as Long COVID.

4 Sep 2024

Global mental illness risks linked to commercial factors

Umbrella review identifies how commercial factors like smoking, alcohol consumption, ultra-processed foods, and social media use contribute significantly to mental illness and suicidal behaviors across various populations.

2 Sep 2024

NCCS study uses exosomes to overcome resistance to epidermal growth factor receptor inhibitors

In a new study, clinician-scientists and researchers from the National Cancer Centre Singapore (NCCS) have demonstrated the use of exosomes to successfully target squamous cell cancer tumours that are usually resistant to epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs). Their research is the first where exosomes have been applied to target TKI-resistant cancers in Singapore. The findings were published in the journal Developmental Cell last month.

2 Sep 2024

Tips for parents to safeguard children from online gaming risks

As online gaming becomes an increasingly popular pastime among children, parents continue to grow concerned about the potential risks and dangers their children may be facing.

30 Aug 2024

Study reveals neural processes behind morphine's pain relief

In a study published in Science, researchers at Karolinska Institutet describe the neural processes behind how morphine relieves pain. This is valuable knowledge because the drug has such serious side effects.

29 Aug 2024

Massachusetts monthly gamblers report rising problems and negative attitudes

In the latest of three online gambling surveys conducted by the University of Massachusetts Amherst, monthly gamblers in Massachusetts reported an increase in gambling intensity and gambling harms. In addition, their attitudes toward gambling have grown more negative.

29 Aug 2024

North Carolina's residential opioid treatment services lack evidence-based approaches

A new study of organizations that claim to provide residential opioid substance use services in North Carolina found that only 12% of the organizations were licensed by the state to provide residential substance use treatment. What's more, only about a quarter of the organizations even allowed patients to access the only treatment for opioid use disorder proven to reduce overdose deaths.

29 Aug 2024

Psychedelics: A new hope for substance abuse treatment

Study explores the history and current state of psychedelic research for treating substance abuse disorders, highlighting challenges like restrictive policies, lack of funding, and the need for recognition of traditional and modern therapeutic practices.

28 Aug 2024

Recreational drug users three times more likely to experience repeat cardiovascular events

New research presented at this year's ESC Congress 2024 in London, UK (30 Aug – 2 Sept) shows that, among patients admitted to the intensive cardiac care unit (ICCU), those with a recent history of recreational drug use are three times more likely than those with no history to experience a repeat serious cardiovascular event within one year.

28 Aug 2024

NIH funds study on psychedelics' potential to treat methamphetamine addiction

John McCorvy, PhD, Assistant Professor in the Department of Cell Biology, Neurobiology, and Anatomy at the Medical College of Wisconsin (MCW); Adam Halberstadt, PhD, Professor of Psychiatry at the University of California San Diego (UCSD) and Director of the UCSD Center for Psychedelic Research; and Kevin Murnane, PhD, Associate Professor of Pharmacology, Toxicology, and Neuroscience and Director of Basic Science Research for the Louisiana Addiction Research Center at LSU Health Shreveport, were recently awarded a five-year, $2.4 million research grant from the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), to uncover critical insights into how psychedelics could be used as a therapeutic to treat methamphetamine addiction.

27 Aug 2024

Public voices often ignored in states’ opioid settlement money decisions

The conversation wasn't sounding good for Kensington residents on June 20. The Philadelphia neighborhood is a critical center of the nation's opioid crisis, and the city had decided to spend $7.5 million in opioid settlement money to improve the quality of life there.

27 Aug 2024